Epidemiology and risk factors for extension of necrotizing otitis externa

Eur Arch Otorhinolaryngol. 2024 May;281(5):2383-2394. doi: 10.1007/s00405-024-08549-5. Epub 2024 Mar 18.

Abstract

Purpose: Necrotizing otitis externa (OEN) is an aggressive and morbid infection of the external acoustic meatus. What are the risk factors for OEN extension?

Methods: French monocentric retrospective study (2004-2021), including patients with OEN defined by the association of an inflamed EAM, a positive nuclear imaging, the presence of a bacteriological sample and the failure of a well-followed local and/or general antibiotic treatment. OEN was extensive if it was associated with vascular or neurological deficits, if nuclear imaging fixation and/or bone lysis extended beyond the tympanic bone.

Results: Our population (n = 39) was male (74%), type 2 diabetic (72%), aged 75.2 years and pseudomonas aeruginosa was found in 88% of cases. Complications for 43% of patients were extensive fixation on nuclear imaging, for 21% of them the presence of extensive bone lysis, for 13% the appearance of facial palsy, for 5.3% the presence hypoglossal nerve palsy and for 2.5% the presence of thrombophlebitis or other nerves palsies. 59% of our population had extensive OEN. The diagnosis of the extensive OEN was made 22 days later (p = 0.04). The clinical presentation was falsely reassuring due to easier identification of the tympanic membrane (70% vs 46%, p = 0.17) but associated with periauricular oedema (42% vs 0%), bone exposure (16% vs 0%) and a temporomandibular joint pain (41% vs 12%).

Conclusion: Delayed treatment of OEN, identification of clinical bone lysis, especially when the tympanic membrane is easily visualized, and the presence of unbalanced diabetes are potential risk factors for extension of OEN.

Keywords: Diabetes; Necrotizing otitis externa; Osteomyelitis; Otalgia; Scintigraphy.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Ear Canal
  • Humans
  • Male
  • Otitis Externa* / diagnosis
  • Otitis Externa* / epidemiology
  • Pseudomonas Infections* / epidemiology
  • Retrospective Studies
  • Risk Factors

Substances

  • Anti-Bacterial Agents